Trial: 202012180

A PHASE II STUDY OF CHECKPOINT BLOCKADE IMMUNOTHERAPY IN PATIENTS WITH SOMATICALLY HYPERMUTATED RECURRENT GLIOBLASTOMA

Phase

II

Principal Investigator

Johanns, Tanner

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov